Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Victrex PLC Board/Management Information 2015

Mar 23, 2015

5290_rns_2015-03-23_421c5e01-6769-4236-8614-670c092d7cf8.html

Board/Management Information

Open in viewer

Opens in your device viewer

{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 0783I

Victrex PLC

23 March 2015

23 March 2015

Victrex plc - Directorate change

Victrex appoints Martin Court to the Board

The Board of Victrex plc, an innovative world leader in high performance polymer solutions, is pleased to announce the appointment of Dr Martin Court as an Executive Director, effective from 1 April 2015.

Martin, who joined Victrex in February 2013, is Managing Director of Invibio, Victrex's medical business. Invibio focuses on solutions for the spinal fusion market, as well as developing solutions for the dental, trauma and knee markets. His appointment further strengthens the Board, with Victrex's other divisional managing director, Tim Cooper, Managing Director of Victrex Polymer Solutions, already an Executive Director.

Martin, aged 53, has a wealth of proven international experience in the medical and high performance polymer industry, including with Cytec Industries, and in a number of senior roles at both ICI and UCB. He is an INSEAD alumni, holds a doctorate in the field of surface chemistry and fracture mechanics and a BSc (Eng) degree in mineral technology from Imperial College of Science and Technology.

Larry Pentz, Chairman of Victrex, said: "I am delighted to welcome Martin to the Board. His appointment reflects not only a natural progression, in having both of our divisional heads on the Board, but that an important part of our future portfolio will be in high value medical markets."

David Hummel, Chief Executive of Victrex, said: "Martin has helped refine our focus on the high value growth platforms that will further develop the market for PEEK in the future, in line with our strategy and as the market leader. I look forward to Martin joining the Board and his continued contribution to Victrex."

About Victrex:

Victrex is an innovative world leader in high performance polymer solutions, focused on the strategic markets of Automotive, Aerospace, Energy, Electronics and Medical. Every day, millions of people rely on products or applications which contain our materials, from smartphones, aeroplanes and cars to oil & gas operations and medical devices. With over 35 years' experience, we are investing in technical excellence to deliver new and leading edge solutions to our customers and our markets, and to drive value for our shareholders. Find out more at www.victrexplc.com

Notes:

Upon his appointment to the Board, Martin will receive a basic salary of £257,000. He will also be eligible to participate in the Company's short and long term executive incentive programmes, as outlined in Victrex's Annual Report.

Enquiries:

Victrex plc:

Andrew Hanson, Head of Investor Relations & Communications                 +44 (0) 1253 898121

Pendomer Communications:

Charlie Armitstead                                                                                 +44 (0) 203 603 5220

This information is provided by RNS

The company news service from the London Stock Exchange

END

BOAEALDEADNSEFF